title: Rivaroxaban and false positive lupus anticoagulant testing.
authors.forename: Eileen
authors.initials: E
authors.lastname: Merriman
authors.forename: Zane
authors.initials: Z
authors.lastname: Kaplan
authors.forename: Jenny
authors.initials: J
authors.lastname: Butler
authors.forename: Erica
authors.initials: E
authors.lastname: Malan
authors.forename: Eng
authors.initials: E
authors.lastname: Gan
authors.forename: Huyen
authors.initials: H
authors.lastname: Tran
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D016736:Antiphospholipid Syndrome / Q000097:blood / Q000175:diagnosis* / Q000276:immunology; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests; D005189:False Positive Reactions; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000097:blood*; D009025:Morpholines / Q000009:adverse effects / Q000627:therapeutic use*; D010314:Partial Thromboplastin Time; D011237:Predictive Value of Tests; D011517:Prothrombin Time; D000069552:Rivaroxaban; D013876:Thiophenes / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D054556:Venous Thromboembolism / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D016682:Lupus Coagulation Inhibitor; D009025:Morpholines; D013876:Thiophenes; D014859:Warfarin; D000069552:Rivaroxaban